tiprankstipranks
China Resources Pharmaceutical Group Ltd. (DE:640)
FRANKFURT:640

China Resources Pharmaceutical Group Ltd. (640) Income Statement

0 Followers

China Resources Pharmaceutical Group Ltd. Income Statement

Last quarter (Q2 2022), China Resources Pharmaceutical Group Ltd.'s total revenue was HK$―, a decrease of ― from the same quarter last year. In Q2, China Resources Pharmaceutical Group Ltd.'s net income was HK$―. See China Resources Pharmaceutical Group Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
-HK$ 236.81BHK$ 200.42BHK$ 204.45BHK$ 189.69BHK$ 172.53B
Cost of Revenue
-HK$ 201.43BHK$ 168.13BHK$ 170.44BHK$ 154.76BHK$ 144.26B
Gross Profit
-HK$ 35.38BHK$ 32.29BHK$ 34.02BHK$ 34.93BHK$ 28.28B
Operating Expense
-HK$ 23.20BHK$ 20.97BHK$ 23.93BHK$ 23.13BHK$ 18.12B
Operating Income
-HK$ 12.18BHK$ 11.32BHK$ 10.08BHK$ 11.80BHK$ 10.16B
Net Non Operating Interest Income Expense
-HK$ -2.02BHK$ -2.48BHK$ -3.08BHK$ -2.93BHK$ -2.23B
Other Income Expense
------
Pretax Income
-HK$ 8.41BHK$ 7.08BHK$ 6.64BHK$ 9.18BHK$ 8.58B
Tax Provision
-HK$ 1.76BHK$ 1.75BHK$ 1.54BHK$ 1.61BHK$ 1.72B
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-HK$ 3.77BHK$ 3.30BHK$ 3.29BHK$ 3.98BHK$ 3.48B
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
-HK$ 224.63BHK$ 189.10BHK$ 194.37BHK$ 177.89BHK$ 162.37B
Net Income From Continuing And Discontinued Operation
-HK$ 3.77BHK$ 3.30BHK$ 3.29BHK$ 3.98BHK$ 3.48B
Normalized Income
-HK$ 4.44BHK$ 4.96BHK$ 4.09BHK$ 4.03BHK$ 3.66B
Interest Expense
-HK$ 2.74BHK$ 3.15BHK$ 3.71BHK$ 2.93BHK$ 2.23B
EBIT
-HK$ 11.15BHK$ 10.23BHK$ 10.35BHK$ 12.12BHK$ 10.81B
EBITDA
-HK$ 13.98BHK$ 12.67BHK$ 12.72BHK$ 13.73BHK$ 12.38B
Currency in HKD

China Resources Pharmaceutical Group Ltd. Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis